Humanigen Statistics

Total Valuation

Humanigen has a market cap or net worth of $23,816. The enterprise value is -$3.07 million.

Market Cap	23,816
Enterprise Value	-3.07M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Humanigen has 119.08 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	119.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.35%
Owned by Institutions (%)	0.49%
Float	110.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.01
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-233.90%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$283,167
Profits Per Employee	-$8.94M
Employee Count	6
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.89% in the last 52 weeks. The beta is -1.05, so Humanigen's price volatility has been lower than the market average.

Beta (5Y)	-1.05
52-Week Price Change	-99.89%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	40.53
Average Volume (20 Days)	19,667

Short Selling Information

The latest short interest is 3.60 million, so 3.02% of the outstanding shares have been sold short.

Short Interest	3.60M
Short Previous Month	3.32M
Short % of Shares Out	3.02%
Short % of Float	3.26%
Short Ratio (days to cover)	1.52

Income Statement

In the last 12 months, Humanigen had revenue of $1.70 million and -$53.63 million in losses. Loss per share was -$0.54.

Revenue	1.70M
Gross Profit	1.70M
Operating Income	-52.01M
Pretax Income	-53.63M
Net Income	-53.63M
EBITDA	-51.43M
EBIT	-51.43M
Loss Per Share	-$0.54

Full Income Statement

Balance Sheet

The company has $3.10 million in cash and no debt, giving a net cash position of $3.10 million or $0.03 per share.

Cash & Cash Equivalents	3.10M
Total Debt	n/a
Net Cash	3.10M
Net Cash Per Share	$0.03
Equity (Book Value)	-49.73M
Book Value Per Share	-0.42
Working Capital	-48.27M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-64.32M
Capital Expenditures	n/a
Free Cash Flow	-64.32M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -3,061.21% and -3,156.80%.

Gross Margin	100.00%
Operating Margin	-3,061.21%
Pretax Margin	-3,156.80%
Profit Margin	-3,156.80%
EBITDA Margin	-3,027.19%
EBIT Margin	-3,027.19%
FCF Margin	-3,785.46%

Dividends & Yields

Humanigen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.55%
Shareholder Yield	-81.55%
Earnings Yield	-225,201.55%
FCF Yield	-270,049.55%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 14, 2020. It was a reverse split with a ratio of 1:5.

Last Split Date	Sep 14, 2020
Split Type	Reverse
Split Ratio	1:5

Scores

Humanigen has an Altman Z-Score of -231.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-231.89
Piotroski F-Score	1